Asymchem Laboratories (Tianjin) Co., Ltd.

ISIN CNE100002BZ6

 | 

WKN A2DUQX

Market cap (in EUR)
4,356 m
Country
China
Sector
Healthcare
Dividend yield
1.10%
 

Overview

Description

Asymchem Laboratories (Tianjin) Co., Ltd. engages in the research and development, and production of intermediates, and active pharmaceutical ingredients. Its business scopes include small molecule contract development and manufacturing organization (CDMO), and emerging service businesses. Its Small Molecule CDMO business provides process development and analysis, clinical drug production, new drug application and approval services, and current good manufacturing practice commercial production services. Its Emerging Service business covers chemical macromolecules, formulations, biosynthesis technology, biological macromolecules, and clinical research services. The company was founded by Hao Hong on October 7, 1998 and is headquartered in Tianjin, China.
Show more Show less
Healthcare Healthcare Services Outsourced Development and Manufacturing Services China

Financials

Key metrics

Market capitalisation, EUR 4,356 m
EPS, EUR 0.37
P/B ratio 2.0
P/E ratio 34.5
Dividend yield 1.10%

Income statement (2024)

Revenue, EUR 736 m
Net income, EUR 122 m
Profit margin 16.57%

What ETF is Asymchem Laboratories (Tianjin) Co., Ltd. in?

There are 15 ETFs which contain Asymchem Laboratories (Tianjin) Co., Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Asymchem Laboratories (Tianjin) Co., Ltd. is the JPMorgan China A Research Enhanced Index Equity (ESG) UCITS ETF USD (dist).
ETF Weight Investment focus Fund size (in m EUR)
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating 0.00%
Equity
World
Multi-Asset Strategy
896
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
14
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
67
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
193
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
683
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
497
Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing 0.00%
Equity
Emerging Markets
Social/Environmental
15
Vanguard FTSE All-World UCITS ETF (USD) Accumulating 0.00%
Equity
World
27,971
JPMorgan China A Research Enhanced Index Equity (ESG) UCITS ETF USD (dist) 0.09%
Equity
China
Social/Environmental
5
Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating 0.00%
Equity
Emerging Markets
1,428
Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing 0.00%
Equity
Emerging Markets
2,759
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
34
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
89
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
87
Vanguard FTSE All-World UCITS ETF (USD) Distributing 0.00%
Equity
World
19,168
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.